World Investment Advisors Acquires 796 Shares of Intuitive Surgical, Inc. $ISRG

World Investment Advisors grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,596 shares of the medical equipment provider’s stock after acquiring an additional 796 shares during the period. World Investment Advisors’ holdings in Intuitive Surgical were worth $867,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after buying an additional 453,335 shares in the last quarter. Invesco Ltd. grew its stake in shares of Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the period. Northern Trust Corp grew its stake in shares of Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the period. Wellington Management Group LLP increased its holdings in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Finally, Nuveen LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 0.8%

ISRG opened at $534.28 on Friday. The company has a market capitalization of $191.53 billion, a PE ratio of 70.67, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The firm has a 50-day simple moving average of $464.32 and a two-hundred day simple moving average of $498.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Rothschild & Co Redburn upped their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a report on Tuesday, October 21st. Finally, The Goldman Sachs Group upped their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the transaction, the insider owned 17,120 shares of the company’s stock, valued at $9,352,142.40. This trade represents a 14.06% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 96,011 shares of company stock worth $50,309,042. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.